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cells, HFE and HAMP expressions were elevated only at 
low 1 g/L treatment (p < 0.03) and were repressed at 2 g/L 
treatment (p < 0.03). Under holotransferrin-untreated con-
ditions, the iron-loaded recombinant cells showed higher 
expressions of HFE (p < 0.03) and HAMP (p = 0.05) than 
wild-type cells. HFE mRNA was independently elevated 
by extracellular and intracellular iron-excess. Thus, it may 
be involved in sensing both, extracellular and intracellular 
iron. Repression of HAMP expression under simultaneous 
intracellular and extracellular iron-loading resembles non-
hereditary iron-excess pathologies.
Keywords HFE · Iron-sensing · Holotransferrin · 
Hepcidin
Abbreviations
EMEM  Eagle’s minimal essential medium
Holo-Tf  Holotransferrin
H  Hours
Gene annotations
HAMP  Gene encoding hepcidin
HFE  Gene encoding haemochromatosis protein HFE
Introduction
Maintenance of cellular and systemic iron homeostasis 
in the body is a dynamic process involving several signal 
transduction pathways. The haemochromatosis protein 
HFE maintains body iron homeostasis by participating in 
the induction of hepcidin (HAMP), the systemic iron regu-
lator, by a yet incompletely understood mechanism [1–3]. 
Mutations in the genes HFE or HAMP causes diminished 
hepcidin production which results in systemic and tissue 
Abstract In liver hepatocytes, the HFE gene regulates cel-
lular and systemic iron homeostasis by modulating cellular 
iron-uptake and producing the iron-hormone hepcidin in 
response to systemic iron elevation. However, the mecha-
nism of iron-sensing in hepatocytes remain enigmatic. 
Therefore, to study the effect of iron on HFE and hepcidin 
(HAMP) expressions under distinct extracellular and intra-
cellular iron-loading, we examined the effect of holotrans-
ferrin treatment (1, 2, 5 and 8 g/L for 6 h) on intracellular 
iron levels, and mRNA expressions of HFE and HAMP in 
wild-type HepG2 and previously characterized iron-loaded 
recombinant-TfR1 HepG2 cells. Gene expression was ana-
lyzed by real-time PCR and intracellular iron was meas-
ured by ferrozine assay. Data showed that in the wild-type 
cells, where intracellular iron content remained unchanged, 
HFE expression remained unaltered at low holotransfer-
rin treatments but was upregulated upon 5 g/L (p < 0.04) 
and 8 g/L (p = 0.05) treatments. HAMP expression showed 
alternating elevations and increased upon 1 g/L (p < 0.05) 
and 5 g/L (p < 0.05). However, in the recombinant cells 
that showed higher intracellular iron levels than wild-type 
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iron overload, referred as hereditary haemochromatosis 
[4]. However, despite the presence of functional wild-
type alleles of these genes, low to moderate tissue iron 
excess is also observed in non-hereditary conditions such 
as alcoholic liver disease, hepatitis C infections, non-
alcoholic fatty liver disease, non-alcoholic steato hepatitis 
and type 2 diabetes [5–8]. In these cases, iron loading can 
exacerbate the pathophysiology via excess-iron-induced 
oxidative stress [9]. Thus, it is important to fully delin-
eate their iron-sensing mechanisms to formulate thera-
peutic interventions, particularly for the low-moderate 
iron-loaded conditions where, unlike hereditary hemo-
chromatosis, phlebotomy is not practiced for removal of 
excess iron.
The mRNA response of HFE to increasing extra-
cellular and intracellular iron and its relationship with 
HAMP expression at transcript level have not been stud-
ied so far. Hence, in this short study, we investigated the 
effect of a range of holotransferrin (holo-Tf) concentra-
tions (1–8 g/L) on HFE and HAMP mRNA expressions, 
and intracellular iron content. First, we observed these 
responses in the wild type (Wt) HepG2 cells, where 
holo-Tf supplementation represent physiological condi-
tions with extracellular (systemic) iron elevation prior 
to intracellular/tissue iron loading. Then, we examined 
the responses in the previously characterized recombinant 
(rec)-TfR1 HepG2 cells [10]. As these cells can achieve 
intracellular iron overloading [10], holo-Tf supplemen-
tation to these cells represent pathological conditions, 
which show simultaneously increased extracellular (sys-
temic) and intracellular iron levels. Finally, to understand 
the exclusive effect of high intracellular iron content, we 
compared the expression levels between holo-Tf-untreated 
Wt and recombinant cells. Unlike most previous holo-Tf 
supplementation studies that were conducted at longer 
time-points of 24, 48 or 72 h [11–13], here, we studied 
the effect following 6 h of holotransferrin treatment to 
examine early responses.
Materials and methods
Cell culture and treatments
Maintenance of cells and holo-Tf supplementation to the 
Wt HepG2 cells (Health Protection Agency, UK) and rec-
TfR1 HepG2 cells was as described previously [10]. Cells 
were treated with holo-Tf (1, 2, 5 and 8 g/L) prepared in 
serum-free EMEM (0 g/L) for 6 h and assessed for vari-
ous parameters. As 8 g/L holo-Tf represent a very high 
concentration and the rec-TfR1 HepG2 cells had the poten-
tial for intracellular iron-overloading following holo-Tf 
supplementation [10], the effect of this concentration was 
studied only in Wt cells.
Determination of intracellular iron content
Cellular iron content determined by ferrozine assay [14] 
was normalized to protein, content, as quantified by Brad-
ford method. Iron levels were expressed as nmoles iron/mg 
protein.
Gene expression analysis
Primers (Invitrogen, UK) for expression analyses, RNA 
extraction, cDNA conversion and assessment for mRNA 
expression via real-time PCR by using Quantifast SYBR 
green kit (Qiagen, UK), was as previously described [10, 
15]. Data was analyzed by the relative quantification method, 
Delta–Delta  Ct (∆∆Ct) and expressed as  2−∆∆Ct [16].
Statistical analysis
Data analysis was performed using one-way ANOVA. The 
level of significance was set at p < 0.05. Data was presented 
as mean ± SEM (n = 3).
Results
In the Wt cells, while intracellular iron content remained 
unaltered following holo-Tf supplementation (Fig. 1a), 
HFE mRNA expression significantly increased by 3.5-fold 
(p < 0.04) upon 5 g/L treatment and further increased by 4.5-
fold (p = 0.05) upon 8 g/L treatment (Fig. 1b). Expression 
levels remained unaltered at lower concentrations of 1 and 
2 g/L (Fig. 1b). Differentially, HAMP expression showed 
a pattern of alternating responses i.e. a significant 1.8-fold 
(p < 0.05) up-regulation upon 1 g/L treatment, unaltered 
expression upon 2 g/L treatment followed by a significant 
2.3-fold up-regulation upon 5 g/L treatment (p < 0.05) and 
then, down-regulation upon 8 g/L treatment (Fig. 1c).
Prior to expression studies in the recombinant cells, 
intracellular iron loading was confirmed. Data showed that 
following treatment with most holo-Tf concentrations, intra-
cellular iron content in these cells was higher than Wt cells 
(Figs. 1a, 2a). In the recombinant cells, over the increasing 
holo-Tf concentrations, although intracellular iron content 
decreased at 2 g/L (p < 0.01), it increased at 5 g/L treatment 
(p < 0.03) that restored the high levels, as in untreated con-
ditions (Fig. 2a). These cells differed from the Wt cells in 
HFE and HAMP expression patterns. Here, HFE expression 
increased upon 1 g/L (p = 0.07), but then decreased upon 
2 g/L holo-Tf treatment (p < 0.03), and remained unaltered 
at 5 g/L (Fig. 2b). Similarly, HAMP expression increased 
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by 3.5-fold at 1 g/L (p < 0.03) followed by a repression at 
2 g/L (p < 0.03)and remained unaltered at 5 g/L treatment 
(Fig. 2c).
Further, to understand the exclusive effect of intracellu-
lar iron loading, HFE and HAMP expressions in untreated 
cells were compared. Data showed that the recombinant cells 
expressed higher levels of HFE and HAMP mRNA than Wt 
cells (2.3-fold; p < 0.03 and 3.9-fold; p = 0.05, respectively) 
(Fig. 3a, b).
Discussion
The genes HFE and HAMP are extremely important for 
maintaining body iron homeostasis, where the protein HFE 
modulates HAMP induction [1, 2] and the induced peptide 
hepcidin regulates systemic iron homeostasis upon systemic 
iron elevation [17, 18]. However, the intracellular and extra-
cellular iron-sensing mechanisms remain unclear and the 
upstream responses of the HFE mRNA to increasing extra-
cellular and intracellular iron levels and its co-relation with 
HAMP mRNA have been rarely studied. Therefore, in this 
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Fig. 1  Effects of holo-Tf supplementation in Wt HepG2 cells. Wt 
HepG2 cells were treated with holo-Tf for 6 h. Following the treat-
ment, intracellular iron levels were measured and expressed per mg 
protein (a). HFE (b) and HAMP (c) mRNA expressions was assessed 
and expressed relative to untreated (0 g/L) cells. Data is presented as 
mean ± SEM (n = 3). *p ≤ 0.05 compared to untreated (0 g/L) controls
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Fig. 2  Effects of holo-Tf supplementation in rec-TfR1 HepG2 cells. 
Rec-TfR1 HepG2 cells were treated with holo-Tf for 6 h. Following 
the treatment, intracellular iron levels were measured and expressed 
per mg protein (a). HFE (b) and HAMP (c) mRNA expressions was 
assessed and expressed relative to untreated (0  g/L) cells. Data is 
presented as mean ± SEM (n = 3). *p < 0.03, **p < 0.01 and #p = 0.07 
compared to untreated (0 g/L) controls. ^p < 0.03 compared to 2 g/L 
treatment
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short study we aimed to discriminate between the effects of 
intracellular and extracellular iron-loading. Hence, we exam-
ined HFE and HAMP expressions under high extracellular 
iron levels, high intracellular iron levels, and simultaneously 
increased intracellular and extracellular iron levels by treat-
ing Wt and recombinant HepG2 cells with/without a range 
of increasing holo-Tf concentrations. Such studies will not 
only help in elucidating the iron-sensing mechanisms but 
also in understanding iron-acquisition in non-hereditary 
iron-excess conditions.
HFE mRNA expression is responsive to excess 
extracellular and intracellular iron
In our knowledge, no study has yet reported the effect of 
increasing holo-Tf concentration or saturation on HFE 
mRNA levels. We report for the first time, that increas-
ing extracellular holo-Tf concentration causes elevation in 
HFE mRNA expression in the Wt HepG2 cells (Fig. 1b). 
As this increase occurred in the absence of intracellular 
iron elevation (Fig. 1a), it could be attributed exclusively 
to the elevated extracellular holo-Tf concentrations, 
thereby demonstrating the responsiveness of HFE mRNA 
towards excess extracellular iron. Furthermore, high HFE 
mRNA expression in the absence of extracellular iron, 
but presence of high intracellular iron (as observed in 
untreated recombinant cells) can be attributed exclusively 
to the high intracellular iron content (Figs. 1a, 2a, 3a). This 
indicates the responsiveness of HFE mRNA exclusively 
to high intracellular content. Collectively, HFE mRNA 
expression showed independent sensitivity to extracellular 
and intracellular iron loading.
HAMP mRNA expression and iron
In the Wt cells, elevation of HAMP expression following 
holo-Tf supplementation (Fig. 1c) is an expected response 
following an iron stimulus [17, 19, 20]. These elevations 
occurred in the absence of increased intracellular iron, 
indicating that an increase in extracellular iron was suf-
ficient for the induction and a major increase in intracel-
lular iron content was not necessary. Interestingly, its 
wavy pattern of expression over the increasing holo-Tf 
concentrations displayed a typical hormonal characteris-
tic where increased levels of a stimulant (here, holo-Tf) 
may not lead to a directly proportional mRNA response. 
This is because, unlike cytokines, hormone-peptides are 
‘premade’ and released from vesicles following a stimu-
lus, like incase of insulin [21]. In the absence of extracel-
lular iron (untreated cells), the high HAMP expression in 
recombinant cells (Fig. 3b), indicated that HAMP could be 
induced exclusively due to high intracellular iron content 
(Figs. 1a, 2a).
Interrelationship between HFE and HAMP expression 
patterns
A correlation between the mRNA responses of HFE and 
HAMP over the increasing holo-Tf concentrations was 
envisaged. The Wt cells showed no co-relation between the 
patterns of their responses (Fig. 1b, c), probably reflecting 
the hormonal characteristic of hepcidin. Conversely, the 
recombinant cells showed similarities between the patterns 
of HFE and HAMP expressions (Fig. 2b, c). Data in the 
recombinant showed that under intracellular iron excess, 
only subtle extracellular iron elevation could elevate HFE 
and HAMP expressions and further increase in extracellu-
lar iron led to either repression or an unaltered effect. This 
implies that both these genes can be induced by an external 
iron stimulus to regulate iron homeostasis, but preferably 
in the absence of intracellular iron loading. This could be 
a reason for deregulated iron metabolism and insufficient 
hepcidin production in non-hereditary iron excess conditions 
that show both, systemic and cellular iron loading, despite 
the presence of functional alleles of these genes.
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Fig. 3  HFE and HAMP mRNA expressions in rec-TfR1 HepG2 cells 
relative to Wt HepG2 cells. The mRNA expressions of HFE (a) and 
HAMP (b) in the recombinant cells were expressed relative to Wt 
HepG2 cells under untreated conditions at the 6 h time point. Data is 
presented as mean ± SEM (n = 3). *p ≤ 0.05 compared to Wt HepG2 
cells
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Further studies are required to elucidate these mecha-
nisms to better understand the iron-sensing and iron-loading 
mechanisms; aiming to design therapeutic interventions for 
the non-hereditary iron-excess pathologies.
Conclusion
In this short study, the independent effects of extracellular 
and intracellular iron on HFE and HAMP expressions were 
examined. HFE mRNA demonstrated independent respon-
siveness to elevated extracellular and intracellular iron con-
tent, suggesting its involvement in sensing both, extracel-
lular and intracellular iron. Under combined intracellular 
and extracellular iron loading, HFE and HAMP expressions 
showed similar patterns and HAMP was induced only by 
low holo-Tf concentration, a scenario resembling iron excess 
pathologies.
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